Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197
Maria Laura Bellone, Andrea Puglisi, Fabrizio Dal Piaz, Alejandro Hochkoeppler
Topics & Concepts
ImmunogenicityEscherichia coliRecombinant DNACoronavirus disease 2019 (COVID-19)VirologyBiologyChemistryComputational biologyAntibodyBiochemistryGeneticsGeneMedicineInfectious disease (medical specialty)DiseasePathologyToxin Mechanisms and ImmunotoxinsSARS-CoV-2 and COVID-19 ResearchClostridium difficile and Clostridium perfringens research